Imagenebio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Imagenebio Inc's ROI in the second quarter of 2026?
Imagenebio Inc recorded a cumulative net loss of $-52 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -37.03%.

Within the Healthcare sector 391 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3407 to 3550.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	145	130	142	150	-177
Return On Investment (TTM)	-37.03 %	-81.75 %	350.56 %	54.48 %	-
IMA's Overall Ranking	# 3550	# 3407	# 3158	# 2212	# 0
Seq. Investment Change TTM	132.27 %	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-52	-50	-45	-48	-26

IMA Company Profile >> Back to IMA Roi Comparisons >> See Annual IMA Return On Investment

Return On Investment IMA's Ranking
Within:	No.
Industry	# 53
Sector	# 392
Overall	# 3550

Return On Investment Statistics
High	Average	Low
-14.16 %	-32.34 %	-41.52 %
(Dec 31 2021)		(Mar 31 2023)

Financial Statements
Imagenebio Inc's II. Quarter Investments	$ 145 Millions	IMA's Balance sheet
Imagenebio Inc's II. Quarter Income	$ -10 Millions	Quarterly IMA's Income Statement
IMA's Income by Division		See IMA's Income by Division

IMA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	142	131	178	151	221
Y / Y Investment Growth	8.42 %	-26.51 %	18 %	-31.69 %	-
Net Income in Millions	-45	-49	-68	-69	-34
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-31.99 %	-37.66 %	-38.32 %	-45.61 %	-15.46 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMA's Competitors
Subscribers only: Roi for Imagenebio Inc's Suppliers
Subscribers only: Return On Investment for IMA's Customers

Other Ratios
IMA's Roa	IMA's Inventory Turnover Ratio	IMA's Growth Rates	IMA's Dividend Statistics
	IMA's Profitability Ratios	IMA's Asset Turnover Ratio	IMA's Dividend Growth
IMA's Roe	IMA's Valuation Ratios	IMA's Financial Strength Ratios	IMA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-10T13:46:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.